P2.10-01 ALKTERNATE: A Pilot Study Alternating Lorlatinib with Crizotinib in Patients with ALK+ NSCLC and ALK-inhibitor Resistance by Itchins, M., Liang, S., Brown, C., Barnes, T., Marx, G., Chin, V., Kao, S., Yip, P.Y., Mersiades, A.J., Nagrial, A., Bray, V., Peters, G., Parakh, S., John, T., Li, M., Li, B.T., McKay, M., Molloy, M., O'Byrne, K., Lee, C., Gill, A., Solomon, B.J., Pavlakis, N.

Get full text